NEW ORLEANS - A Tangipahoa Parish resident has filed a lawsuit against the manufacturers of a prescription blood thinner claiming the drug caused him to suffer severe internal bleeding.
Anthony Ougle filed suit against Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GMBH & Co. KG, Boehringer Ingelheim International GMBH, Bidachem S.P.A. on Aug. 14 in federal court in New Orleans.
The defendants are accused of selling, distributing, and manufacturing the “defective and unreasonably dangerous drug” Pradaxa, which is a prescription medication used as a blood thinner.
Ougle claims that in January 2013 he suffered severe internal bleeding as a result of ingesting the drug.
Ougle argues that the drug was defectively designed, inadequately tested, dangerous to human health, and lacked proper warnings as to the dangers associated with its use.
The plaintiff is seeking an award of damages for disfigurement, conscious pain, suffering, mental anguish, mental suffering, embarrassment, shame, loss of enjoyment of life, loss of association, loss of earnings, loss of profits, loss of salary, medical expenses, mental and physical impairment, actual damages, economic damages, including lost wages, interest, and court costs.
Ougle is represented by New Orleans attorneys John D. Sileo and Kevin P. Riche. A jury trial is requested.
U.S. District Judge Lance M. Africk is assigned to the case.
Case No. 2:13-cv-05428